Isomerase today announced that it has been certified to the ISO9001-2015 standard for quality management systems. This certification is a testament to the company's commitment to quality and continuous improvement.
ISO9001 is an international standard that specifies requirements for a quality management system. The standard helps organizations to improve their performance by providing a framework for managing quality.
Isomerase is a leading provider of biotechnology research and development services, including microbiology, fermentation, bioengineering, chemistry, downstream processing and bioinformatics. The company has been in business for over ten years and has a strong commitment to quality. The ISO9001 certification is a significant achievement for the company and demonstrates its commitment to providing its customers with the highest quality products and services.
“Achieving ISO9001-2015 certification is another significant milestone for Isomerase.,” said Simon Aspland, CEO of Isomerase. “As Isomerase has continued to grow, we have evolved to help our customers further along their journey to commercialization. This certification provides further reassurance to our customers who naturally have come to expect the highest quality products and services from Isomerase. Isomerase is committed to continuous improvement, and our recent ISO9001-2015 certification is important external validation of the progress we have made.”
ISO9001-2015 is a standard recognized by businesses and organizations around the world to improve quality and performance.
For more information about Isomerase, please visit www.isomerase.com
Isomerase is a leading innovation partner for all aspects of microbial product and process discovery and development, including leading-edge synthetic biology, advanced strain improvement of microorganisms, genome sequence analysis, protein and peptide expression and isolation, fermentation and process development, DSP, compound isolation, analytical development and synthetic chemistry. In addition, Isomerase manages other aspects necessary for a commercially successful program on behalf of partners, such as compound management and shipping and scaled manufacture.
We offer these capabilities underpinned by a portfolio of technology IP, and the combined experience of a core technical and leadership team with a substantive track record of successful product discovery and development collaborations with pharma and biotech companies.
We have supported numerous companies with a wide variety of microbial product and small molecule fermentation and synthetic chemistry projects, helping advance early-stage concepts into valuable development programs, and then continuing to support their progress to market with process improvement and scaled manufacture.
For more information please contact Isomerase via our contact page.